Acology Continues Strong Pace, Highlights of 10Q in Letter to Shareholders
May 15, 2017 12:32 pm UTC| Business
CORONA, Calif., May 15, 2017 -- A Letter from CEO Curt Fairbrother Dear Shareholders: With Friday’s release of our 10Q our company’s health and strength continues to be decisively displayed along with the...
Acology Continues Strong Pace, Highlights of 10Q in Letter to Shareholders
May 15, 2017 12:32 pm UTC| Business
CORONA, Calif., May 15, 2017 -- A Letter from CEO Curt Fairbrother Dear Shareholders: With Friday’s release of our 10Q our company’s health and strength continues to be decisively displayed along with the...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
HOFFMAN ESTATES, Ill., May 15, 2017 -- CDK Global, Inc. (“CDK”) announced today its entry into an accelerated share repurchase (“ASR”) agreement with Bank of America Merrill Lynch (“BofAML”) to purchase $350 million of...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...
May 15, 2017 12:32 pm UTC| Business
NEWTOWN, Pa., May 15, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a...